Georges Beaud

910 total citations
49 papers, 768 citations indexed

About

Georges Beaud is a scholar working on Virology, Molecular Biology and Ecology. According to data from OpenAlex, Georges Beaud has authored 49 papers receiving a total of 768 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Virology, 20 papers in Molecular Biology and 18 papers in Ecology. Recurrent topics in Georges Beaud's work include Poxvirus research and outbreaks (23 papers), Bacteriophages and microbial interactions (18 papers) and Virus-based gene therapy research (17 papers). Georges Beaud is often cited by papers focused on Poxvirus research and outbreaks (23 papers), Bacteriophages and microbial interactions (18 papers) and Virus-based gene therapy research (17 papers). Georges Beaud collaborates with scholars based in France, United States and Canada. Georges Beaud's co-authors include David P. Leader, Péter Lengyel, Arban Domi, D.H. Háyes, Réal Lemieux, John Waterson, Jean‐Claude Sagot, Ginette Jauréguiberry, F. Chapeville and Kurt Paucker and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Georges Beaud

47 papers receiving 713 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Georges Beaud France 19 367 330 297 234 204 49 768
D. H. Metz Tanzania 13 372 1.0× 259 0.8× 275 0.9× 163 0.7× 226 1.1× 18 804
C. Jungwirth Germany 17 381 1.0× 261 0.8× 319 1.1× 123 0.5× 270 1.3× 60 905
Alonzo D. García United States 14 394 1.1× 241 0.7× 140 0.5× 92 0.4× 219 1.1× 19 633
Kenneth Abremski United States 15 900 2.5× 213 0.6× 450 1.5× 224 1.0× 63 0.3× 15 1.2k
Poul Andersson Denmark 10 322 0.9× 83 0.3× 106 0.4× 97 0.4× 297 1.5× 13 691
Henry O. Stone United States 14 363 1.0× 62 0.2× 136 0.5× 138 0.6× 283 1.4× 21 732
D. Thinès Belgium 9 362 1.0× 141 0.4× 80 0.3× 61 0.3× 102 0.5× 10 594
Martin Trávníček Czechia 13 521 1.4× 79 0.2× 225 0.8× 116 0.5× 172 0.8× 34 945
Nigel R. Burns United Kingdom 13 270 0.7× 188 0.6× 58 0.2× 100 0.4× 130 0.6× 20 602
Per Elias Sweden 25 551 1.5× 137 0.4× 374 1.3× 93 0.4× 896 4.4× 43 1.5k

Countries citing papers authored by Georges Beaud

Since Specialization
Citations

This map shows the geographic impact of Georges Beaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georges Beaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georges Beaud more than expected).

Fields of papers citing papers by Georges Beaud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Georges Beaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georges Beaud. The network helps show where Georges Beaud may publish in the future.

Co-authorship network of co-authors of Georges Beaud

This figure shows the co-authorship network connecting the top 25 collaborators of Georges Beaud. A scholar is included among the top collaborators of Georges Beaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Georges Beaud. Georges Beaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beaud, Georges, Bernard Klonjkowski, François Piumi, et al.. (2024). Vaccinia Virus Defective Particles Lacking the F17 Protein Do Not Inhibit Protein Synthesis: F17, a Double-Edged Sword for Protein Synthesis?. International Journal of Molecular Sciences. 25(3). 1382–1382. 2 indexed citations
2.
Giustiniani, Jérôme, Anne Marie‐Cardine, Georges Beaud, et al.. (2005). Protocadherin 15 (PCDH15): a new secreted isoform and a potential marker for NK/T cell lymphomas. Oncogene. 25(19). 2807–2811. 23 indexed citations
3.
Beaud, Georges, et al.. (2000). Identification of sites phosphorylated by the vaccinia virus B1R kinase in viral protein H5R. BMC Biochemistry. 1(1). 2–2. 15 indexed citations
5.
Bolbach, Gérard, et al.. (1999). Identification by mass spectroscopy of three major early proteins associated with virosomes in vaccinia virus-infected cells. Virus Research. 59(1). 1–12. 23 indexed citations
6.
Domi, Arban, Georges Beaud, & A. Favre. (1996). Transcripts containing a small anti-HIV hammerhead ribozyme that are active in the cell cytoplasm but inactive in vitro as free RNAs. Biochimie. 78(7). 654–662. 8 indexed citations
7.
Beaud, Georges. (1995). Vaccinia virus DNA replication: A short review. Biochimie. 77(10). 774–779. 26 indexed citations
8.
Domi, Arban, et al.. (1995). PHOTOINACTIVATION (365 NM) OF VACCINIA AND HERPES SIMPLEX VIRUSES INDUCED BY A NEW BUILT‐IN DNA PHOTOSENSITIZER: 4‐THIOTHYMIDINE. Photochemistry and Photobiology. 61(5). 463–470. 5 indexed citations
9.
Ludosky, Marie‐Aline, et al.. (1994). Cell Line-Dependent Release of HIV-Like Gag Particles after Infection of Mammalian Cells with Recombinant Vaccinia Viruses. AIDS Research and Human Retroviruses. 10(4). 383–390. 4 indexed citations
11.
Beaud, Georges. (1994). Control of messenger RNA stability. Trends in Biochemical Sciences. 19(6). 261–262. 61 indexed citations
12.
Beaud, Georges, et al.. (1990). Variable Proteolytic Cleavage of gag Precursor Expressed After Infection of Several Cell Lines with an HIV-2 gag-pol Recombinant Vaccinia Virus. AIDS Research and Human Retroviruses. 6(3). 271–273. 3 indexed citations
14.
Beaud, Georges, et al.. (1987). Characterization of vaccinia virus early promoters and evaluation of their informational content. Journal of Molecular Biology. 198(4). 619–631. 19 indexed citations
15.
Malpièce, Y., et al.. (1987). Identification of vaccinia promoters by heterologous expression of hepatitis B surface antigen in mouse cells infected by recombinant vaccinia viruses. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 910(3). 240–244.
16.
Buendia, Brigitte, et al.. (1987). Ribosomal protein phosphorylation in vivo and in vitro by vaccinia virus. European Journal of Biochemistry. 162(1). 95–103. 21 indexed citations
17.
Beaud, Georges. (1986). Vers un renouveau du virus de la vaccine. médecine/sciences. 2(2). 94–94.
18.
Nielsen, Peter, et al.. (1984). Translation in micrococcal nuclease-treated cell-free extracts from Ehrlich ascites tumor cells. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 783(2). 152–157. 7 indexed citations
19.
Beaud, Georges, et al.. (1983). Mapping of a mutation site in the thymidine kinase gene of vaccinia virus by marker rescue. Annales de l Institut Pasteur Virologie. 134(3). 375–385. 8 indexed citations
20.
Pothier, Pierre, et al.. (1981). The Inhibition of Vaccinia Virus Replication by 5,6-Dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB): an Effect at the Assembly Stage. Journal of General Virology. 55(1). 87–94. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026